COMPASS THERAPEUTICS INC's ticker is CMPX and the CUSIP is 20454B104. A total of 74 filers reported holding COMPASS THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $433,755 | +13.1% | 433,755 | +123.9% | 0.00% | – |
| Q1 2024 | $383,659 | -50.2% | 193,767 | -60.8% | 0.00% | – |
| Q4 2023 | $770,784 | +27.6% | 494,092 | +61.1% | 0.00% | – |
| Q3 2023 | $604,047 | +16.2% | 306,623 | +87.6% | 0.00% | – |
| Q2 2023 | $519,822 | +16149.5% | 163,466 | -83.3% | 0.00% | -100.0% |
| Q1 2023 | $3,199 | +676.5% | 978,403 | +1093.9% | 0.00% | – |
| Q4 2022 | $412 | -99.7% | 81,947 | +29.7% | 0.00% | – |
| Q3 2022 | $144,000 | +94.6% | 63,187 | +126.8% | 0.00% | – |
| Q2 2022 | $74,000 | +39.6% | 27,861 | -27.7% | 0.00% | – |
| Q1 2022 | $53,000 | +51.4% | 38,545 | +245.5% | 0.00% | – |
| Q4 2021 | $35,000 | – | 11,157 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Owl Capital Holdings LP | 2,829,712 | $2,829,712 | 0.79% |
| MPM BioImpact LLC | 5,005,086 | $5,005,086 | 0.78% |
| Orbimed Advisors | 22,362,850 | $22,362,850 | 0.44% |
| Vivo Capital, LLC | 3,556,023 | $3,556,023 | 0.33% |
| CM Management, LLC | 310,000 | $310,000 | 0.28% |
| CAXTON CORP | 43,465 | $43,465 | 0.22% |
| Rock Springs Capital Management LP | 5,513,788 | $5,513,788 | 0.17% |
| Cormorant Asset Management, LP | 2,030,823 | $2,030,823 | 0.12% |
| Ground Swell Capital, LLC | 124,394 | $124,394 | 0.10% |
| Monashee Investment Management LLC | 500,000 | $500,000 | 0.06% |